US-HEALTH-VIRUS

In this photo illustration a Gilead logo is displayed on a smartphone next to a screen showing a coronavirus graphic on March 25, 2020 in Arlington, Virginia. - Gilead announced on March 25, 2020 that it has submitted a request to the Food and Drug Administration to rescind the exclusive marketing rights it had secured for remdesivir, an antiviral drug that shows promise in treating Covid-19, the disease caused by the new coronavirus. (Photo by Olivier DOULIERY / AFP) (Photo by OLIVIER DOULIERY/AFP via Getty Images)
In this photo illustration a Gilead logo is displayed on a smartphone next to a screen showing a coronavirus graphic on March 25, 2020 in Arlington, Virginia. - Gilead announced on March 25, 2020 that it has submitted a request to the Food and Drug Administration to rescind the exclusive marketing rights it had secured for remdesivir, an antiviral drug that shows promise in treating Covid-19, the disease caused by the new coronavirus. (Photo by Olivier DOULIERY / AFP) (Photo by OLIVIER DOULIERY/AFP via Getty Images)
US-HEALTH-VIRUS
購買授權
我可如何使用此圖片?
HK$3,500.00
HKD

詳情

限制條件:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
來源:
OLIVIER DOULIERY / Contributor
編輯性內容編號:
1208237136
圖像集:
AFP
建立日期:
2020年03月25日
上傳日期:
授權類型:
發佈資訊:
無許可授權 更多資料
來源:
AFP
Barcode:
AFP
物件名稱:
AFP_1Q67SP
最大檔案大小:
4000 x 2507 像素 (33.87 x 21.23 cm) - 300 dpi - 2 MB